The Sphenopalatine Ganglion Block for Post-dural Puncture Headache
The Sphenopalatine Ganglion Block as a Treatment Modality for Post-dural Puncture Headache in the Post-partum Patient
Sponsor: Brigham and Women's Hospital
Listed as NCT03385772, this NA trial focuses on Post-Dural Puncture Headache and remains ongoing. Sponsored by Brigham and Women's Hospital, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jun 2018 — Jan 2020 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
Jan 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.